Literature DB >> 23822831

Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim.

Jecko Thachil1, Ian Salter, James N George.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23822831     DOI: 10.1111/ejh.12165

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  7 in total

Review 1.  Evidence-based management of immune thrombocytopenia: ASH guideline update.

Authors:  Cindy E Neunert; Nichola Cooper
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Novel treatments for immune thrombocytopenia.

Authors:  Andrew Shih; Ishac Nazi; John G Kelton; Donald M Arnold
Journal:  Presse Med       Date:  2014-03-20       Impact factor: 1.228

3.  Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial.

Authors:  Yaqiong Tang; Jia Chen; Qifa Liu; Tiantian Chu; Tingting Pan; Jianying Liang; Xue Feng He; Feng Chen; Ting Yang; Xiao Ma; Xiaojin Wu; Shaoyan Hu; Xingyu Cao; Xiaohui Hu; Jiong Hu; Yuejun Liu; Jiaqian Qi; Yueping Shen; Changgeng Ruan; Yue Han; Depei Wu
Journal:  Blood Adv       Date:  2021-03-09

4.  Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice.

Authors:  Monica Carpenedo; Silvia Cantoni; Veronica Coccini; Marilena Fedele; Enrica Morra; Enrico Maria Pogliani
Journal:  Hematol Rep       Date:  2015-02-24

5.  Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain.

Authors:  María-Eva Mingot-Castellano; Carlos Grande-García; David Valcárcel-Ferreiras; Clara Conill-Cortés; Loreto de Olivar-Oliver
Journal:  Case Rep Hematol       Date:  2017-06-11

6.  Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method.

Authors:  Adam Cuker; Jenny M Despotovic; Rachael F Grace; Caroline Kruse; Michele P Lambert; Howard A Liebman; Roger M Lyons; Keith R McCrae; Vinod Pullarkat; Jeffrey S Wasser; David Beenhouwer; Sarah N Gibbs; Irina Yermilov; Michael S Broder
Journal:  Res Pract Thromb Haemost       Date:  2020-12-08

Review 7.  Emerging Concepts in Immune Thrombocytopenia.

Authors:  Maurice Swinkels; Maaike Rijkers; Jan Voorberg; Gestur Vidarsson; Frank W G Leebeek; A J Gerard Jansen
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.